Emrok O is an advanced fluoroquinolone antibiotic developed to combat multidrug-resistant gram-positive and gram-negative bacteria. It inhibits DNA gyrase and topoisomerase IV enzymes, disrupting bacterial DNA replication and leading to cell death.
Recommended for:
Emrok O should be taken orally as prescribed by the physician. Shake well before use. Dosage is determined based on the severity of the infection and patient condition. Typical treatment duration is 5 to 14 days.
Contraindications
Side effects